Showing results (1701-1710 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Immune surveillance and natural resistance: an evaluationW Den OtterCancer Immunology, Immunotherapy : CII|March 31, 2018
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancerDaniel Rojas-Sepúlveda, Andrés Tittarelli, María Alejandra Gleisner, et al.Cancer Immunology, Immunotherapy : CII|February 10, 2018
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysisTao Jiang, Meng Qiao, Chao Zhao, et al.Cancer Immunology, Immunotherapy : CII|February 28, 2018
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinomaVinod Varki, Olga B Ioffe, Soren M Bentzen, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivoT Yoshioka, M Fukuzawa, Y Takai, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cellsM Sensi, L Grazioli, G ParmianiCancer Immunology, Immunotherapy : CII|February 18, 2018
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expressionAlbert T Gacerez, Casey K Hua, Margaret E Ackerman, et al.Cancer Immunology, Immunotherapy : CII|February 18, 2018
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumorsSumit Mukherjee, Rahman Hussaini, Richard White, et al.Cancer Immunology, Immunotherapy : CII|February 23, 2018
Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?S M Mansour Haeryfar, Christopher R Shaler, Patrick T RudakPageof 652